The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a progressive disease that can eventually lead to complications including acute urinary retention (AUR) and the need for BP...

Full description

Bibliographic Details
Main Authors: Eric H. Kim, John A. Brockman, Gerald L. Andriole
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Asian Journal of Urology
Subjects:
Benign prostatic hyperplasia
5-alpha reductase inhibitors
Lower urinary tract symptoms
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388217300929

Similar Items

Similar Items